...Very good morning, everyone. Thank you so much for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and we're really pleased to have with us Mike Cloonan, President and CEO of Sionna. Mike, to start here, can you provide an overview of Sionna's story, including the company's history, strategy, as well as recent pipeline progress? Just given the recent IPO, I think it'll be great to level set everyone listening. Mike Cloonan ...